James Hambro & Partners’s AbbVie ABBV Stock Holding History

James Hambro & Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	2,091 +1	+0%	+$215	0.02%	49
2026 Q1	$454K	Buy	2,090 +435	+26%	+$96.5K	0.02%	43
2025 Q4	$378K	Hold	1,655	–	–	0.01%	43
2025 Q3	$383K	Sell	1,655 -95	-5%	-$19.3K	0.01%	47
2025 Q2	$325K	Hold	1,750	–	–	0.01%	44
2025 Q1	$367K	Hold	1,750	–	–	0.02%	47
2024 Q4	$311K	Sell	1,750 -235	-12%	-$43.2K	0.01%	51
2024 Q3	$392K	Hold	1,985	–	–	0.02%	47
2024 Q2	$340K	Sell	1,985 -79	-4%	-$13.1K	0.02%	46
2024 Q1	$375K	Buy	2,064 +79	+4%	+$13.6K	0.02%	45
2023 Q4	$308K	Sell	1,985 -170	-8%	-$24.8K	0.02%	46
2023 Q3	$321K	Hold	2,155	–	–	0.02%	46
2023 Q2	$290K	Buy	2,155 +391	+22%	+$57.3K	0.02%	54
2023 Q1	$281K	Buy	1,764 +4	+0.2%	+$612	0.02%	59
2022 Q4	$284K	Sell	1,760 -40	-2%	-$6.13K	0.02%	58
2022 Q3	$241K	Sell	1,800 -30	-2%	-$4.3K	0.02%	58
2022 Q2	$281K	Sell	1,830 -110	-6%	-$16.8K	0.02%	53
2022 Q1	$315K	Buy	1,940 +350	+22%	+$50.8K	0.02%	55
2021 Q4	$216K	Buy	+1,590	New	+$188K	0.01%	71

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

James Hambro & Partners's ABBV Position: Q2 2026 in Review

James Hambro & Partners increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $215 and bringing the position to 2,091 shares worth $526K. The position accounts for 0.02% of the portfolio, ranked #49.

James Hambro & Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

James Hambro & Partners held 2,091 shares of AbbVie worth $526K as of Q2 2026.
James Hambro & Partners bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.02% of James Hambro & Partners's portfolio in Q2 2026, its #49 holding.
James Hambro & Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on James Hambro & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.